Targin oxycodone/naloxone regulatory update

EMA's CHMP recommended approval of Targin oxycodone/naloxone from Mundipharma to treat severe to very severe idiopathic restless legs syndrome (RLS) after failure of dopaminergic therapy. The abuse-de...